| 1 | Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual | Ca-A Cancer Journal for Clinicians | 2017 | 1,991 |
| 2 | Current treatment and recent progress in gastric cancer | Ca-A Cancer Journal for Clinicians | 2021 | 1,301 |
| 3 | Cervical cancer: A global health crisis | Cancer | 2017 | 1,015 |
| 4 | Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual | Ca-A Cancer Journal for Clinicians | 2017 | 799 |
| 5 | Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer | Cancer Communications | 2018 | 652 |
| 6 | Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment | Ca-A Cancer Journal for Clinicians | 2017 | 614 |
| 7 | Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations—2019 update | International Journal of Gynecological Cancer | 2019 | 603 |
| 8 | Steps toward mapping the human vasculature by phage display | Nature Medicine | 2002 | 578 |
| 9 | Small cell lung cancer: Where do we go from here? | Cancer | 2015 | 542 |
| 10 | Guidelines for Perioperative Care for Liver Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations | World Journal of Surgery | 2016 | 537 |
| 11 | Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian | Cancer | 2015 | 468 |
| 12 | Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer‐related cognitive impairment in adults | Ca-A Cancer Journal for Clinicians | 2015 | 451 |
| 13 | Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells | Proceedings of the National Academy of Sciences of the United States of America | 2016 | 411 |
| 14 | Guidelines for Perioperative Care for Pancreatoduodenectomy: Enhanced Recovery After Surgery (ERAS) Recommendations 2019 | World Journal of Surgery | 2020 | 396 |
| 15 | Mesothelioma: Scientific clues for prevention, diagnosis, and therapy | Ca-A Cancer Journal for Clinicians | 2019 | 392 |
| 16 | Nanoparticle-mediated Hyperthermia in Cancer Therapy | Therapeutic Delivery | 2011 | 388 |
| 17 | Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop | Journal of Bone and Mineral Research | 2022 | 371 |
| 18 | Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade | Gut | 2019 | 364 |
| 19 | Uveal melanoma: From diagnosis to treatment and the science in between | Cancer | 2016 | 363 |
| 20 | Biliary cancer: Utility of next‐generation sequencing for clinical management | Cancer | 2016 | 362 |
| 21 | Hilar Cholangiocarcinoma: expert consensus statement | Hpb | 2015 | 360 |
| 22 | Assessing the risk of second malignancies after modern radiotherapy | Nature Reviews Cancer | 2011 | 350 |
| 23 | Double hit lymphoma: the MD Anderson Cancer Center clinical experience | British Journal of Haematology | 2014 | 342 |
| 24 | Improving patient and caregiver outcomes in oncology: Team‐based, timely, and targeted palliative care | Ca-A Cancer Journal for Clinicians | 2018 | 331 |
| 25 | Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE‐MRI derived biomarkers in multicenter oncology trials | Journal of Magnetic Resonance Imaging | 2019 | 326 |
| 26 | Targeting the indoleamine 2,3-dioxygenase pathway in cancer | | 2015 | 323 |
| 27 | Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual | Ca-A Cancer Journal for Clinicians | 2018 | 319 |
| 28 | Gastroenteropancreatic high‐grade neuroendocrine carcinoma | Cancer | 2014 | 310 |
| 29 | Prevalence and characteristics of moderate to severe fatigue: A multicenter study in cancer patients and survivors | Cancer | 2014 | 306 |
| 30 | Clinical and molecular characterization of early‐onset colorectal cancer | Cancer | 2019 | 303 |
| 31 | Adrenal cortical carcinoma | World Journal of Surgery | 2001 | 298 |
| 32 | Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011 | Psycho-Oncology | 2013 | 297 |
| 33 | Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer | Molecular Systems Biology | 2014 | 294 |
| 34 | The symptom burden of cancer: Evidence for a core set of cancer‐related and treatment‐related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study | Cancer | 2013 | 289 |
| 35 | A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors | | 2018 | 282 |
| 36 | Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial | Cancer | 2020 | 274 |
| 37 | Mutational spectrum in a worldwide study of 29,700 families withBRCA1orBRCA2mutations | Human Mutation | 2018 | 273 |
| 38 | Report of the AAPM TG‐256 on the relative biological effectiveness of proton beams in radiation therapy | Medical Physics | 2019 | 268 |
| 39 | Report of AAPM Task Group 235 Radiochromic Film Dosimetry: An Update to TG‐55 | Medical Physics | 2020 | 267 |
| 40 | Mitochondrion‐Anchoring Photosensitizer with Aggregation‐Induced Emission Characteristics Synergistically Boosts the Radiosensitivity of Cancer Cells to Ionizing Radiation | Advanced Materials | 2017 | 256 |
| 41 | ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers | Proceedings of the National Academy of Sciences of the United States of America | 2014 | 254 |
| 42 | Cognitive Function as a Predictor of Survival in Patients With Recurrent Malignant Glioma | Journal of Clinical Oncology | 2000 | 253 |
| 43 | Degeneration of Bioprosthetic Heart Valves: Update 2020 | Journal of the American Heart Association | 2020 | 252 |
| 44 | The immune system in cancer metastasis: friend or foe? | | 2017 | 248 |
| 45 | Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature | | 2019 | 248 |
| 46 | Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions | Ca-A Cancer Journal for Clinicians | 2023 | 245 |
| 47 | Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience | | 2019 | 241 |
| 48 | Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms | American Journal of Surgery | 1994 | 240 |
| 49 | Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial | | 2020 | 237 |
| 50 | Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature | | 2019 | 236 |
